Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 9 recruiting now early-phase tilt small index

Viral Infection: early-phase trial registry

9 of 12 indexed Viral Infection trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,429 of 28,707 conditions by registered trial count.

12 US clinical trials · 9 currently recruiting · #1,429 of 28,707 conditions by registered trial count

Viral Infection: 12 US clinical trials tracked, 9 recruiting.

Viral Infection is the subject of 12 registered US clinical trials on ClinicalTrials.gov, 9 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 9 in Phase 1-2 (earlier-stage). The most active sponsor is Children's Hospital Medical Center, Cincinnati, running 4 of these trials.

Enrollment posture brief

Registry condition viral-infection

OPEN 9 | RECR 75% | LATE 0 | EARLY 9 | RANK #1429 | SPON 4

Nearest open-share peer: Activity, Motor (75% recruiting · 8 trials)

Viral Infection (this)75%Acute Myeloid Leukemia in Re41.7%Adenocarcinoma of the Rectum41.7%Adherence, Patient16.7%Accelerated Phase Chronic My0%
Open-enrollment share among volume-matched conditions near Viral Infection

Viral Infection lists 9 open slots (75% of 12 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Viral Infection on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Viral Infection is recruiting above its size-band peers.

    9 of 12 indexed trials (75%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Viral Infection research.

    Children's Hospital Medical Center, Cincinnati accounts for 4 of 12 trials (33.3%). 9 distinct sponsors appear on at least one study for this condition label.

  3. Typical Viral Infection enrolment sits around 180 participants.

    Median target enrolment is 180 among the 12 trials that report a genuine target (sentinel values excluded). 6 of those (50%) plan for fewer than 100 participants.

  4. Viral Infection research is mostly interventional.

    12 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 15Phase 24

Open and recent trials

12 total, page 1 of 1

RECRUITING Phase 2 750 participants

Third Party Viral Specific T-cells (VSTs)

Children's Hospital Medical Center, Cincinnati

NCT02532452

RECRUITING Phase 1 750 participants

Donor-Derived Viral Specific T-cells (VSTs)

Children's Hospital Medical Center, Cincinnati

NCT02048332

RECRUITING NA 200 participants

School Inner City Air Study

Massachusetts General Hospital

NCT05953233

RECRUITING NA 200 participants

Effects of Mouthrinse on the Microbiome of the Oral Cavity and GI Tract

University of California, Irvine

NCT05603650

RECRUITING Phase 2 180 participants

Trial of Scheduled Versus Treatment Administration of Donor-Derived Viral Specific T-cells for Viral Infections After Stem Cell Transplant

Children's Hospital Medical Center, Cincinnati

NCT04230356

RECRUITING Phase 1 48 participants

Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts

Children's National Research Institute

NCT04691622

RECRUITING Phase 1 47 participants

TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.

Baylor College of Medicine

NCT04013802

RECRUITING Phase 1 40 participants

Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)

New York Medical College

NCT04197596

RECRUITING Phase 1 36 participants

Adoptive Cord Blood Immunotherapy for EBV, CMV, BKV and Adenovirus Reactivation/Infection or Prophylaxis

Catherine Bollard

NCT03594981

ACTIVE NOT RECRUITING NA 200 participants

Rapid Diagnosis of Viral Acute Respiratory Infection to Decrease Unnecessary Antibiotic Utilization in the Emergency Department (RADIATE)

Christopher Payette

NCT06271655

ACTIVE NOT RECRUITING Phase 2 42 participants

Viral Specific T-cells for Treatment of Viral Infections After Solid Organ Transplant

Children's Hospital Medical Center, Cincinnati

NCT04331275

COMPLETED Phase 2 27 participants

Smell Changes & Efficacy of Nasal Theophylline

Washington University School of Medicine

NCT03990766

Phase Distribution

PhaseTrial count
Phase 1 5
Phase 2 4

Named interventions

Most-linked intervention names on Viral Infection records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Saline Nasal Drug
1 trials
SPOTFIRE R Panel Device
1 trials
Viral Specific T-cells (VSTs) Biological
1 trials
Viral specific VST Infusion Biological
1 trials
BK CTL Biological
1 trials
Norovirus -specific T-cell (NST) therapy Biological
1 trials
Listerine rinse Other
1 trials
Lumineux Oral Essentials rinse Other
1 trials

US sites by state

Facility locations filed on Viral Infection trials. A trial with sites in several states counts in each.

Ohio 5 trials
Texas 2 trials
Missouri 2 trials
Maryland 2 trials
California 2 trials
Wisconsin 1 trials
Pennsylvania 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Viral Infection page

12 registered trials, 9 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Viral Infection condition card totals 12 registered trials; most-linked intervention Saline Nasal; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.